EBMT-EHA CAR-T 2019 | Managing CAR T-cell therapy toxicities within treatment centres

Christine Chomienne

Christine Chomienne, MD, PhD, of St. Louis Hospital, Paris, France, talks about managing toxicities that may arise with CAR T-cell therapy at the 1st European CAR T-Cell Meeting, held in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).

Share this video